Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $2.31, $0.06 better than the analyst estimate of $2.25. Revenue for the quarter came in at $5.1 million versus the consensus estimate of $5.3 million.

GUIDANCE:

Thermo Fisher Scientific sees FY2017 EPS of $9.29-$9.38, versus the consensus of $9.35. Thermo Fisher Scientific sees FY2017 revenue of $20.50-2.66 billion, versus the consensus of $20.51 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.